We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Collaboration to Develop Neurodegenerative Tests

By HospiMedica staff writers
Posted on 10 Apr 2002
A licensing agreement and a research collaboration for the development of in vitro diagnostic tests for neurodegenerative diseases related to the presence of abnormal prion proteins in humans and animals has been announced by Abbott Laboratories (Abbott Park, IL, USA) and the University of Zurich (Switzerland).

The abnormal proteins are associated with bovine spongiform encephalopathy (BSE), or mad cow disease, in cattle. More...
The human equivalent is new variant Creutzfeldt Jakob disease (nvCJD). Under the licensing agreement, Abbott obtains nonexclusive rights to the university's technologies for the specific binding of disease-associated prion proteins for use in the field of human and veterinary diagnostics. Abbott also obtains exclusive rights to any improvements made as a result of the collaboration. Under an agreement with Enfer Scientific Ltd., Abbott currently markets a post-mortem diagnostic test used outside the United States for detecting BSE in cattle.

"The University of Zurich's technologies and extensive research expertise in prions represent a significant strength in furthering our ability to develop both human and animal diagnostic tests for the early detection of infectious prions,” said James J. Koziarz, Ph.D., vice president, diagnostic products research and development, Abbott Laboratories.




Related Links:
Abbott
Univ. of Zurich

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.